Diabetes and Obstructive Sleep Apnea in China (DOSA2)
This project aims to develop a clinical pathway for obstructive sleep apnea (OSA) screening, diagnosis and treatment for in-patients with type 2 diabetes mellitus (T2DM) in endocrinology department settings.
It will be completed by three steps.
- Development of screening and diagnostic strategy/tool for OSA among hospitalized patients with T2DM as well as assessing the accuracy of the proposed strategy/tool. 450 T2DM patients are needed to develop the jointly tool and another 450 T2DM patients are recruited to retest it.
- Development of supposed clinical pathway for hospitalized T2DM patients comorbid OSA. Based on the results of step 1 and current guidelines, a drafted clinical pathway will be proposed, and then using Delphi method around 40 to 50 related experts will be recruited to review it.
- Pilot and revise the supposed clinical pathway. 600 T2DM patients are needed to assess the supposed clinical pathway. Four tertiary hospitals in Beijing are participating in the projects.